February 16, 2024 — AMO Pharma Limited, a privately held clinical-stage specialty biopharmaceutical company focusing on rare genetic disorders with limited or no treatment options, announced a collaboration with Population Health Research Institute (PHRI), a joint institute of McMaster University and Hamilton Health Sciences in Canada, to advance a clinical pr

February 15, 2024 — Bayer AG and Asklepios BioPharmaceutical, Inc. (AskBio), a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG, have announced that the first patient has been randomized in the GenePHIT (Gene PHosphatase Inhibition Therapy) trial

February 15, 2024 — Canary Medical, a medical data company focused on the development and commercialization of its patented implantable sensor technology and complementary data and analytics ecosystem, today announced the completion of the first-in-human limited feasibility trial of their Cardiac Auscultation (Acoustic) monitoring sensor device.

February 14, 2024 — The American College of Cardiology’s newest registry offers data-driven insights on cardiac procedures performed in the ambulatory surgery setting through its first-of-its-kind dashboard.

February 14, 2024 — The replacement of regular salt with a salt substitute can reduce incidences of hypertension, or high blood pressure, in older adults without increasing their risk of low blood pressure episodes, according to a recent study published in the Feb.